GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Thera Solutions Ltd (SHSE:688177) » Definitions » EV-to-Revenue

Bio-Thera Solutions (SHSE:688177) EV-to-Revenue : 11.28 (As of Sep. 27, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Bio-Thera Solutions EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Bio-Thera Solutions's enterprise value is ¥8,939.9 Mil. Bio-Thera Solutions's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was ¥792.4 Mil. Therefore, Bio-Thera Solutions's EV-to-Revenue for today is 11.28.

The historical rank and industry rank for Bio-Thera Solutions's EV-to-Revenue or its related term are showing as below:

SHSE:688177' s EV-to-Revenue Range Over the Past 10 Years
Min: 7.15   Med: 21.13   Max: 31323.52
Current: 11.01

During the past 8 years, the highest EV-to-Revenue of Bio-Thera Solutions was 31323.52. The lowest was 7.15. And the median was 21.13.

SHSE:688177's EV-to-Revenue is ranked worse than
57.87% of 1042 companies
in the Biotechnology industry
Industry Median: 7.515 vs SHSE:688177: 11.01

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-09-27), Bio-Thera Solutions's stock price is ¥21.85. Bio-Thera Solutions's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was ¥1.91. Therefore, Bio-Thera Solutions's PS Ratio for today is 11.46.


Bio-Thera Solutions EV-to-Revenue Historical Data

The historical data trend for Bio-Thera Solutions's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Thera Solutions EV-to-Revenue Chart

Bio-Thera Solutions Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial - 64.51 11.09 18.09 24.21

Bio-Thera Solutions Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.62 23.87 24.21 21.02 11.29

Competitive Comparison of Bio-Thera Solutions's EV-to-Revenue

For the Biotechnology subindustry, Bio-Thera Solutions's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Thera Solutions's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Thera Solutions's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Bio-Thera Solutions's EV-to-Revenue falls into.



Bio-Thera Solutions EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Bio-Thera Solutions's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=8939.930/792.415
=11.28

Bio-Thera Solutions's current Enterprise Value is ¥8,939.9 Mil.
Bio-Thera Solutions's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥792.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bio-Thera Solutions  (SHSE:688177) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Bio-Thera Solutions's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=21.85/1.906
=11.46

Bio-Thera Solutions's share price for today is ¥21.85.
Bio-Thera Solutions's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.91.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bio-Thera Solutions EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bio-Thera Solutions's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Thera Solutions Business Description

Traded in Other Exchanges
N/A
Address
5th Floor, Building A6, 11 Kaiyuan Avenue, Guangzhou High-tech Industrial Development Zone, Science City, Guangdong Province, Guangzhou, CHN, 510530
Bio-Thera Solutions Ltd is engaged in research, development, and production of drugs and biosimilars. The company provides drug research and development; biotechnology consulting and communication services; services; medical research and experimental development; biological drug manufacturing; and pharmaceuticals retail.

Bio-Thera Solutions Headlines

No Headlines